Literature DB >> 8463268

The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event.

P A Warmerdam1, N M Nabben, S A van de Graaf, J G van de Winkel, P J Capel.   

Abstract

We have isolated and characterized three genes coding for hFc gamma RIIA, IIB, and IIC. Each gene spans approximately 15-19 kilobases of DNA and consists of eight exons. Two exons encode the 5'-untranslated region and signal peptides, two exons code for homologous Ig-like extracellular domains, a single exon encodes the transmembrane spanning region, and three exons encode the cytoplasmic domains and 3'-untranslated regions. Analysis of gene structures support the concept that the hFc gamma RIIA and hFc gamma RIIB genes originated via gene duplication and divergence processes. The hFc gamma RIIC gene, however, showed a remarkable homology at its 5' end with the hFc gamma RIIB gene, whereas its 3' region was highly homologous with the hFc gamma RIIA gene, suggesting that the hFc gamma RIIC gene results from an unequal crossover event between the hFc gamma RIIA and IIB genes. This hypothesis was supported by nucleotide sequence analyses of the putative break-point region. The proposed site of recombination was located approximately 300 nucleotides downstream from the sixth (C1) exon. These data provide a unique model for the evolutionary generation of a receptor family with multiple biological functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463268

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Functions of the Fc receptors for immunoglobulin G.

Authors:  B K Flesch; J Neppert
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Intravenous immunoglobulins--understanding properties and mechanisms.

Authors:  A Durandy; S V Kaveri; T W Kuijpers; M Basta; S Miescher; J V Ravetch; R Rieben
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

3.  FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.

Authors:  Julien Lejeune; Benoît Piègu; Valérie Gouilleux-Gruart; Marc Ohresser; Hervé Watier; Gilles Thibault
Journal:  MAbs       Date:  2012-10-02       Impact factor: 5.857

4.  The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.

Authors:  M B Callanan; P Le Baccon; P Mossuz; S Duley; C Bastard; R Hamoudi; M J Dyer; G Klobeck; R Rimokh; J J Sotto; D Leroux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.

Authors:  Xinrui Li; Jianming Wu; Travis Ptacek; David T Redden; Elizabeth E Brown; Graciela S Alarcón; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Richard A Kaslow; Robert P Kimberly; Jeffrey C Edberg
Journal:  Sci Transl Med       Date:  2013-12-18       Impact factor: 17.956

6.  Variation in human FCGR2C gene copy number.

Authors:  A F Reilly; S Surrey; E F Rappaport; E Schwartz; S E McKenzie
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression.

Authors:  S Q Nagelkerke; C E Tacke; W B Breunis; J Geissler; J W R Sins; B Appelhof; T K van den Berg; M de Boer; T W Kuijpers
Journal:  Genes Immun       Date:  2015-07-02       Impact factor: 2.676

8.  Evidence for non-random distribution of Fcgamma receptor genotype combinations.

Authors:  W-Ludo van der Pol; Marc D Jansen; Wim J Sluiter; Bart van de Sluis; Fredriek G J Leppers-van de Straat; Tetsuo Kobayashi; Rudi G J Westendorp; Tom W J Huizinga; Jan G J van de Winkel
Journal:  Immunogenetics       Date:  2003-06-26       Impact factor: 2.846

9.  FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

Authors:  Shuying S Li; Peter B Gilbert; Georgia D Tomaras; Gustavo Kijak; Guido Ferrari; Rasmi Thomas; Chul-Woo Pyo; Susan Zolla-Pazner; David Montefiori; Hua-Xin Liao; Gary Nabel; Abraham Pinter; David T Evans; Raphael Gottardo; James Y Dai; Holly Janes; Daryl Morris; Youyi Fong; Paul T Edlefsen; Fusheng Li; Nicole Frahm; Michael D Alpert; Heather Prentice; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Merlin L Robb; Robert J O'Connell; Barton F Haynes; Nelson L Michael; Jerome H Kim; M Juliana McElrath; Daniel E Geraghty
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

Review 10.  CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity.

Authors:  Eugenia Corrales-Aguilar; Katja Hoffmann; Hartmut Hengel
Journal:  Semin Immunopathol       Date:  2014-10-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.